Sasha E. Stanton, MD, PhD
Assistant member, Cancer Immunoprevention Laboratory
Earle A. Chiles Research Institute
Providence Cancer Institute
Providence Cancer Institute
Dr. Stanton is a physician scientist with expertise in breast cancer and extensive training in molecular genetics and immunotherapy. Currently, she leads the Cancer Immunoprevention Laboratory at the Earle A. Chiles Research Institute, a Providence Center of Excellence for immuno-oncology and cellular therapy. She is also a practicing physician at Providence and is board-certified in medical oncology and internal medicine.
Dr. Stanton became interested in breast cancer after witnessing its devastation among friends and family. When she started taking care of patients with cancer, she saw unmet needs that more targeted therapies given earlier in the disease could address. She decided to focus on translational breast cancer research in the emerging field of immuno-oncology.
The Cancer Immunoprevention Lab focuses on the immune response to high-risk precancerous lesions and how immunotherapy may improve both early detection and prevention of cancer.
The lab is studying immunoprevention through vaccines for high-risk patients with pre-invasive breast lesions or oral dysplasia. Dr. Stanton’s goal is to take laboratory-based findings into the clinic and to make a meaningful impact – preventing both the morbidity and mortality associated with invasive cancer.
- Fellowship, Laboratory of Mary (Nora) Disis, M.D., Tumor Vaccine Group, University of Washington, 2013-2015
- Residency in internal medicine, breast research with Linda Vahdat, M.D., and Ellen Chuang, M.D., Ph.D., Weill-Cornell/New York Hospital Breast Oncology, 2008-2011
- Doctor of Medicine and Doctor of Philosophy in molecular genetics, Albert Einstein College of Medicine, 2008
- Bachelor of Arts in biology and classics, Mount Holyoke College, 1998
- Medical oncologist, Providence Cancer Institute, 2020-present
- Assistant member, Cancer Immunoprevention Laboratory, Earle A. Chiles Research Institute, Providence Cancer Institute, 2020-present
- Assistant professor, Cancer Vaccine Institute, University of Washington, 2017-2020
- Acting instructor, Laboratory of Mary (Nora) Disis, M.D., Tumor Vaccine Group, University of Washington, 2015-2017
- Graduate student, Laboratory of Nicole Schreiber-Agus, Ph.D., Albert Einstein College of Medicine, 2003-2006
- Research technician, Laboratory of Matthew Meyerson, M.D., Ph.D., Dana Farber Cancer Institute, 1998-2000
- American Association for Cancer Research
- American Medical Association
- American Society of Clinical Oncology
- American Society of Hematology
- Society for Immunotherapy for Cancer
- Southwest Oncology Group
- Translational Breast Cancer Research Consortium
- Athena endowed award for excellence in breast cancer research, 2017
- Alpha Omega Alpha, 2008
- Honors Master’s Thesis, 2003
- Phi Beta Kappa, 1998
- Turner Award for Excellence in Biological Research, 1998
- Sigma Xi, 1998
- Sarah Williston Award for Academic Achievement, 1996
- Abby Howe-Turner Award in Biology, 1995
Dr. Stanton’s research is published in peer-reviewed scientific and medical journals. She has partnered with colleagues on various research projects.